Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Restricted Stock Units | 1.51M | $1.01M | $0.67 | Feb 13, 2025 | Direct |
LEXICON PHARMACEUTICALS, INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 2.26M | Feb 13, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS, INC. | Feb 13, 2025 | 2 | $0 | 4 | Feb 18, 2025 | Chief Executive Officer, Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Jul 8, 2024 | 1 | $0 | 4 | Jul 8, 2024 | Chief Executive Officer, Director |
LXRX | LEXICON PHARMACEUTICALS, INC. | Jul 8, 2024 | 0 | $0 | 3 | Jul 8, 2024 | Chief Executive Officer, Director |